Insider Transactions in Q4 2025 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
11,000
-3.65%
|
$4,807,000
$437.12 P/Share
|
|
Oct 02
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+18.71%
|
$1,485,000
$135.42 P/Share
|
|
Oct 02
2025
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
4,000
-71.16%
|
$1,736,000
$434.88 P/Share
|
|
Oct 02
2025
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+49.2%
|
$480,000
$120.26 P/Share
|
|
Oct 01
2025
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
4,000
-60.29%
|
$1,700,000
$425.37 P/Share
|
|
Oct 01
2025
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+49.2%
|
$480,000
$120.26 P/Share
|